284 related articles for article (PubMed ID: 11967289)
1. Infectious virions produced from a human papillomavirus type 18/16 genomic DNA chimera.
Meyers C; Bromberg-White JL; Zhang J; Kaupas ME; Bryan JT; Lowe RS; Jansen KU
J Virol; 2002 May; 76(10):4723-33. PubMed ID: 11967289
[TBL] [Abstract][Full Text] [Related]
2. Human papillomavirus type 45 propagation, infection, and neutralization.
McLaughlin-Drubin ME; Wilson S; Mullikin B; Suzich J; Meyers C
Virology; 2003 Jul; 312(1):1-7. PubMed ID: 12890615
[TBL] [Abstract][Full Text] [Related]
3. Propagation, infection, and neutralization of authentic HPV16 virus.
McLaughlin-Drubin ME; Christensen ND; Meyers C
Virology; 2004 May; 322(2):213-9. PubMed ID: 15110519
[TBL] [Abstract][Full Text] [Related]
4. Synthesis of infectious human papillomavirus type 18 in differentiating epithelium transfected with viral DNA.
Meyers C; Mayer TJ; Ozbun MA
J Virol; 1997 Oct; 71(10):7381-6. PubMed ID: 9311816
[TBL] [Abstract][Full Text] [Related]
5. Generation and neutralization of pseudovirions of human papillomavirus type 33.
Unckell F; Streeck RE; Sapp M
J Virol; 1997 Apr; 71(4):2934-9. PubMed ID: 9060652
[TBL] [Abstract][Full Text] [Related]
6. Chimeric human papillomavirus type 16 (HPV-16) L1 particles presenting the common neutralizing epitope for the L2 minor capsid protein of HPV-6 and HPV-16.
Varsani A; Williamson AL; de Villiers D; Becker I; Christensen ND; Rybicki EP
J Virol; 2003 Aug; 77(15):8386-93. PubMed ID: 12857908
[TBL] [Abstract][Full Text] [Related]
7. The role of the human papillomavirus type 18 E7 oncoprotein during the complete viral life cycle.
McLaughlin-Drubin ME; Bromberg-White JL; Meyers C
Virology; 2005 Jul; 338(1):61-8. PubMed ID: 15921717
[TBL] [Abstract][Full Text] [Related]
8. Human Papillomavirus E2 Regulates SRSF3 (SRp20) To Promote Capsid Protein Expression in Infected Differentiated Keratinocytes.
Klymenko T; Hernandez-Lopez H; MacDonald AI; Bodily JM; Graham SV
J Virol; 2016 May; 90(10):5047-58. PubMed ID: 26962216
[TBL] [Abstract][Full Text] [Related]
9. Quantitative role of the human papillomavirus type 16 E5 gene during the productive stage of the viral life cycle.
Genther SM; Sterling S; Duensing S; Münger K; Sattler C; Lambert PF
J Virol; 2003 Mar; 77(5):2832-42. PubMed ID: 12584306
[TBL] [Abstract][Full Text] [Related]
10. Expression of vaccinia recombinant HPV 16 L1 and L2 ORF proteins in epithelial cells is sufficient for assembly of HPV virion-like particles.
Zhou J; Sun XY; Stenzel DJ; Frazer IH
Virology; 1991 Nov; 185(1):251-7. PubMed ID: 1656586
[TBL] [Abstract][Full Text] [Related]
11. Induction of human papillomavirus type 18 late gene expression and genomic amplification in organotypic cultures from transfected DNA templates.
Frattini MG; Lim HB; Doorbar J; Laimins LA
J Virol; 1997 Sep; 71(9):7068-72. PubMed ID: 9261437
[TBL] [Abstract][Full Text] [Related]
12. Human papillomavirus type 16 minor capsid protein l2 N-terminal region containing a common neutralization epitope binds to the cell surface and enters the cytoplasm.
Kawana Y; Kawana K; Yoshikawa H; Taketani Y; Yoshiike K; Kanda T
J Virol; 2001 Mar; 75(5):2331-6. PubMed ID: 11160736
[TBL] [Abstract][Full Text] [Related]
13. In vitro generation and type-specific neutralization of a human papillomavirus type 16 virion pseudotype.
Roden RB; Greenstone HL; Kirnbauer R; Booy FP; Jessie J; Lowy DR; Schiller JT
J Virol; 1996 Sep; 70(9):5875-83. PubMed ID: 8709207
[TBL] [Abstract][Full Text] [Related]
14. Chimeric papillomavirus virus-like particles elicit antitumor immunity against the E7 oncoprotein in an HPV16 tumor model.
Greenstone HL; Nieland JD; de Visser KE; De Bruijn ML; Kirnbauer R; Roden RB; Lowy DR; Kast WM; Schiller JT
Proc Natl Acad Sci U S A; 1998 Feb; 95(4):1800-5. PubMed ID: 9465097
[TBL] [Abstract][Full Text] [Related]
15. Human papillomavirus type 18 chimeras containing the L2/L1 capsid genes from evolutionarily diverse papillomavirus types generate infectious virus.
Bowser BS; Chen HS; Conway MJ; Christensen ND; Meyers C
Virus Res; 2011 Sep; 160(1-2):246-55. PubMed ID: 21762735
[TBL] [Abstract][Full Text] [Related]
16. The human papillomavirus type 16 E7 oncogene is required for the productive stage of the viral life cycle.
Flores ER; Allen-Hoffmann BL; Lee D; Lambert PF
J Virol; 2000 Jul; 74(14):6622-31. PubMed ID: 10864676
[TBL] [Abstract][Full Text] [Related]
17. Neutralization of HPV16, 18, 31, and 58 pseudovirions with antisera induced by immunizing rabbits with synthetic peptides representing segments of the HPV16 minor capsid protein L2 surface region.
Kondo K; Ishii Y; Ochi H; Matsumoto T; Yoshikawa H; Kanda T
Virology; 2007 Feb; 358(2):266-72. PubMed ID: 17010405
[TBL] [Abstract][Full Text] [Related]
18. Human papillomavirus (HPV) L1 and L1-L2 virus-like particle-based multiplex assays for measurement of HPV virion antibodies.
Hernandez BY; Ton T; Shvetsov YB; Goodman MT; Zhu X
Clin Vaccine Immunol; 2012 Sep; 19(9):1348-52. PubMed ID: 22761294
[TBL] [Abstract][Full Text] [Related]
19. Expression of human papillomavirus type 11 L1 protein in insect cells: in vivo and in vitro assembly of viruslike particles.
Rose RC; Bonnez W; Reichman RC; Garcea RL
J Virol; 1993 Apr; 67(4):1936-44. PubMed ID: 8383219
[TBL] [Abstract][Full Text] [Related]
20. In vitro synthesis of oncogenic human papillomaviruses requires episomal genomes for differentiation-dependent late expression.
Frattini MG; Lim HB; Laimins LA
Proc Natl Acad Sci U S A; 1996 Apr; 93(7):3062-7. PubMed ID: 8610168
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
